Clinical Pathway and Monthly Feedback Improve Adherence to Antibiotic Guideline Recommendations for Community-Acquired Pneumonia
暂无分享,去创建一个
Gregory M. Peterson | Syed Tabish R. Zaidi | G. Peterson | S. Zaidi | T. Anderson | Maher Almatar | Angus Thompson | Duncan McKenzie | Tara Anderson | D. McKenzie | A. Thompson | M. Almatar | S. T. Zaidi
[1] CORB is the best pneumonia severity score for elderly hospitalised patients with suspected pneumonia , 2014, Internal medicine journal.
[2] S. Reeves,et al. Implementation Science BioMed Central Debate , 2005 .
[3] G. Peterson,et al. Factors influencing ceftriaxone use in community‐acquired pneumonia: Emergency doctors’ perspectives , 2014, Emergency Medicine Australasia.
[4] Peter J. Embi,et al. Evaluating alert fatigue over time to EHR-based clinical trial alerts: findings from a randomized controlled study , 2012, J. Am. Medical Informatics Assoc..
[5] T. File,et al. Burden of Community-Acquired Pneumonia in North American Adults , 2010, Postgraduate medicine.
[6] Jane M. Young,et al. Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.
[7] Sylvia J. Hysong,et al. Meta-Analysis: Audit and Feedback Features Impact Effectiveness on Care Quality , 2009, Medical care.
[8] S. Bowler,et al. Effect of a simple educational intervention on the hospital management of community‐acquired pneumonia , 2007, Respirology.
[9] C. Rees,et al. A window into the lives of junior doctors: narrative interviews exploring antimicrobial prescribing experiences. , 2014, The Journal of antimicrobial chemotherapy.
[10] S. Corrao,et al. Can CAP guideline adherence improve patient outcome in internal medicine departments? , 2008, European Respiratory Journal.
[11] Jacqueline A Pugh,et al. Audit and feedback and clinical practice guideline adherence: Making feedback actionable , 2006, Implementation science : IS.
[12] M. Ortega,et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] G. Peterson,et al. Community‐acquired pneumonia: why aren't national antibiotic guidelines followed? , 2015, International journal of clinical practice.
[14] M. Whitby,et al. Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department. , 2014, Microbial drug resistance.
[15] T. Marrie,et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.
[16] Michael J Fine,et al. Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Joshua S. Davis,et al. Rocket science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Kylie L Easton,et al. Empiric management of community‐acquired pneumonia in Australian emergency departments , 2005, The Medical journal of Australia.
[20] J. Burke,et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Rory Wolfe,et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] J. Grimshaw,et al. Printed educational materials: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.
[23] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[24] W. Lim,et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.
[25] A D Oxman,et al. Educational outreach visits: effects on professional practice and health care outcomes. , 2007, The Cochrane database of systematic reviews.
[26] S. Allen,et al. From the Australian Commission on Safety and Quality in Health Care , 2011, The Medical journal of Australia.
[27] Scot H Simpson,et al. Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia. , 2005, Respiratory care clinics of North America.
[28] R. Grol,et al. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study , 2007, Quality and Safety in Health Care.